These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The search for nucleoside/nucleotide analog inhibitors of dengue virus. Chen YL; Yokokawa F; Shi PY Antiviral Res; 2015 Oct; 122():12-9. PubMed ID: 26241002 [TBL] [Abstract][Full Text] [Related]
23. Identification of a new dengue virus inhibitor that targets the viral NS4B protein and restricts genomic RNA replication. van Cleef KW; Overheul GJ; Thomassen MC; Kaptein SJ; Davidson AD; Jacobs M; Neyts J; van Kuppeveld FJ; van Rij RP Antiviral Res; 2013 Aug; 99(2):165-71. PubMed ID: 23735301 [TBL] [Abstract][Full Text] [Related]
25. In vitro and in vivo efficacy of Metformin against dengue. Cheang YZN; Ting HRD; Koh HQV; Alonso S Antiviral Res; 2021 Nov; 195():105186. PubMed ID: 34655660 [TBL] [Abstract][Full Text] [Related]
26. The kinase inhibitor SFV785 dislocates dengue virus envelope protein from the replication complex and blocks virus assembly. Anwar A; Hosoya T; Leong KM; Onogi H; Okuno Y; Hiramatsu T; Koyama H; Suzuki M; Hagiwara M; Garcia-Blanco MA PLoS One; 2011; 6(8):e23246. PubMed ID: 21858043 [TBL] [Abstract][Full Text] [Related]
28. Schisandrin A inhibits dengue viral replication via upregulating antiviral interferon responses through STAT signaling pathway. Yu JS; Wu YH; Tseng CK; Lin CK; Hsu YC; Chen YH; Lee JC Sci Rep; 2017 Mar; 7():45171. PubMed ID: 28338050 [TBL] [Abstract][Full Text] [Related]
29. A translation inhibitor that suppresses dengue virus in vitro and in vivo. Wang QY; Kondreddi RR; Xie X; Rao R; Nilar S; Xu HY; Qing M; Chang D; Dong H; Yokokawa F; Lakshminarayana SB; Goh A; Schul W; Kramer L; Keller TH; Shi PY Antimicrob Agents Chemother; 2011 Sep; 55(9):4072-80. PubMed ID: 21730119 [TBL] [Abstract][Full Text] [Related]
30. Exploring the in vitro potential of celecoxib derivative AR-12 as an effective antiviral compound against four dengue virus serotypes. Hassandarvish P; Oo A; Jokar A; Zukiwski A; Proniuk S; Abu Bakar S; Zandi K J Antimicrob Chemother; 2017 Sep; 72(9):2438-2442. PubMed ID: 28666323 [TBL] [Abstract][Full Text] [Related]
32. Antiviral Activity of Compound L3 against Dengue and Zika Viruses In Vitro and In Vivo. Chuang FK; Liao CL; Hu MK; Chiu YL; Lee AR; Huang SM; Chiu YL; Tsai PL; Su BC; Chang TH; Lin CC; Shih CC; Yen LC Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32517029 [TBL] [Abstract][Full Text] [Related]
33. An analogue of the antibiotic teicoplanin prevents flavivirus entry in vitro. De Burghgraeve T; Kaptein SJ; Ayala-Nunez NV; Mondotte JA; Pastorino B; Printsevskaya SS; de Lamballerie X; Jacobs M; Preobrazhenskaya M; Gamarnik AV; Smit JM; Neyts J PLoS One; 2012; 7(5):e37244. PubMed ID: 22624001 [TBL] [Abstract][Full Text] [Related]
34. Narasin, a novel antiviral compound that blocks dengue virus protein expression. Low JS; Wu KX; Chen KC; Ng MM; Chu JJ Antivir Ther; 2011; 16(8):1203-18. PubMed ID: 22155902 [TBL] [Abstract][Full Text] [Related]
35. A quinoline compound inhibits the replication of dengue virus serotypes 1-4 in Vero cells. Beesetti H; Tyagi P; Medapi B; Krishna VS; Sriram D; Khanna N; Swaminathan S Antivir Ther; 2018; 23(5):385-394. PubMed ID: 29583121 [TBL] [Abstract][Full Text] [Related]
36. Discovery of Dengue Virus NS4B Inhibitors. Wang QY; Dong H; Zou B; Karuna R; Wan KF; Zou J; Susila A; Yip A; Shan C; Yeo KL; Xu H; Ding M; Chan WL; Gu F; Seah PG; Liu W; Lakshminarayana SB; Kang C; Lescar J; Blasco F; Smith PW; Shi PY J Virol; 2015 Aug; 89(16):8233-44. PubMed ID: 26018165 [TBL] [Abstract][Full Text] [Related]
37. Inhibition of dengue virus RNA synthesis by an adenosine nucleoside. Chen YL; Yin Z; Duraiswamy J; Schul W; Lim CC; Liu B; Xu HY; Qing M; Yip A; Wang G; Chan WL; Tan HP; Lo M; Liung S; Kondreddi RR; Rao R; Gu H; He H; Keller TH; Shi PY Antimicrob Agents Chemother; 2010 Jul; 54(7):2932-9. PubMed ID: 20457821 [TBL] [Abstract][Full Text] [Related]
38. Inhibition of dengue virus replication by novel inhibitors of RNA-dependent RNA polymerase and protease activities. Pelliccia S; Wu YH; Coluccia A; La Regina G; Tseng CK; Famiglini V; Masci D; Hiscott J; Lee JC; Silvestri R J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1091-1101. PubMed ID: 28776445 [TBL] [Abstract][Full Text] [Related]
39. Geraniin extracted from the rind of Nephelium lappaceum binds to dengue virus type-2 envelope protein and inhibits early stage of virus replication. Abdul Ahmad SA; Palanisamy UD; Tejo BA; Chew MF; Tham HW; Syed Hassan S Virol J; 2017 Nov; 14(1):229. PubMed ID: 29162124 [TBL] [Abstract][Full Text] [Related]
40. Novel benzoxazole inhibitor of dengue virus replication that targets the NS3 helicase. Byrd CM; Grosenbach DW; Berhanu A; Dai D; Jones KF; Cardwell KB; Schneider C; Yang G; Tyavanagimatt S; Harver C; Wineinger KA; Page J; Stavale E; Stone MA; Fuller KP; Lovejoy C; Leeds JM; Hruby DE; Jordan R Antimicrob Agents Chemother; 2013 Apr; 57(4):1902-12. PubMed ID: 23403421 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]